Design, synthesis and pharmacological evaluation of 2-arylurea-1,3,5-triazine derivative (XIN-9): A novel potent dual PI3K/mTOR inhibitor for cancer therapy
Xin Sun(Jiangxi Science and Technology Normal University), Wufu Zhu(Jiangxi Science and Technology Normal University), Shan Xu(First Affiliated Hospital of Xi'an Jiaotong University), Bin He(Guiyang Medical University), Binliang Zhang(Jiangxi Science and Technology Normal University), Yang Yang(Jiangsu University), Qian Zhang(Jiangxi Science and Technology Normal University), Linxiao Wang(Jiangxi Science and Technology Normal University), Pengwu Zheng(Jiangxi Science and Technology Normal University), Leixuan Luo(Jiangxi Science and Technology Normal University)
Cited by 21
Related Papers
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
|Science|2011|1.4k
Overview of lethal human coronaviruses
|Signal Transduction and Targeted Therapy|2020|312
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
|Acta Neuropathologica Communications|2017|306
Identification of a cellularly active SIRT6 allosteric activator
|Nature Chemical Biology|2018|272